Literature DB >> 1003539

Gastric cancer in Colombia. III. Natural history of precursor lesions.

P Correa, C Cuello, E Duque, L C Burbano, F T Garcia, O Bolanos, C Brown, W Haenszel.   

Abstract

The premalignant process in the gastric mucosa was studied by gastroscopic surveys of Colombian populations, and the prevalence of superficial gastritis, chronic atrophic gastritis, and intestinal metaplasia was calculated for population samples having a very high gastric cancer risk (Nariño), very low risk (Cartagena), and intermediate risk (Cali). The prevalence of individuals with normal mucosa in successive age groups was used to estimate "depletion" curves, which were taken as indicators of the dynamics of the premalignant process in each community. Differences corresponding to the geographic variation in stomach cancer risk were found: In the high-risk areas of Nariño, around 75% of the population developed some type of gastritis by 45 years of age, whereas in the low- and intermediate-risk population of Cartagena and Cali, the proportion of such lesions did not exceed 50% at age 45 or thereafter. The effect of environmental factors in early life seemed to be important in determining the prevalence of lesions in each population.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1003539     DOI: 10.1093/jnci/57.5.1027

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  81 in total

1.  Serologic evidence that ascaris and toxoplasma infections impact inflammatory responses to Helicobacter pylori in Colombians.

Authors:  Courtney Ek; Mark T Whary; Melanie Ihrig; Luis E Bravo; Pelayo Correa; James G Fox
Journal:  Helicobacter       Date:  2012-04       Impact factor: 5.753

2.  Promoter DNA hypermethylation in gastric biopsies from subjects at high and low risk for gastric cancer.

Authors:  Barbara G Schneider; Dun-Fa Peng; M Constanza Camargo; M Blanca Piazuelo; Liviu A Sicinschi; Robertino Mera; Judith Romero-Gallo; Alberto G Delgado; Luis E Bravo; Keith T Wilson; Richard M Peek; Pelayo Correa; Wael El-Rifai
Journal:  Int J Cancer       Date:  2010-12-01       Impact factor: 7.396

Review 3.  Overview: Helicobacter pylori and extragastric disease.

Authors:  Hidekazu Suzuki; Barry James Marshall; Toshifumi Hibi
Journal:  Int J Hematol       Date:  2006-11       Impact factor: 2.490

4.  Comparison of precancerous conditions: atrophy and intestinal metaplasia in Helicobacter pylori gastritis among Chinese and Dutch patients.

Authors:  X Y Chen; R W van Der Hulst; Y Shi; S D Xiao; G N Tytgat; F J Ten Kate
Journal:  J Clin Pathol       Date:  2001-05       Impact factor: 3.411

5.  Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men.

Authors:  Meira Epplein; Wei Zheng; Yong-Bing Xiang; Richard M Peek; Honglan Li; Pelayo Correa; Jing Gao; Angelika Michel; Michael Pawlita; Qiuyin Cai; Xiao-Ou Shu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10-03       Impact factor: 4.254

Review 6.  Pathobiology of Helicobacter pylori-Induced Gastric Cancer.

Authors:  Manuel Amieva; Richard M Peek
Journal:  Gastroenterology       Date:  2015-09-16       Impact factor: 22.682

Review 7.  H. pylori infection, inflammation and gastric cancer.

Authors:  Qurteeba Qadri; Roohi Rasool; G M Gulzar; Sameer Naqash; Zafar A Shah
Journal:  J Gastrointest Cancer       Date:  2014-06

Review 8.  Does gastric atrophy exist in children?

Authors:  Georges Dimitrov; Frederic Gottrand
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

9.  Effects of one year's treatment with ranitidine and of truncal vagotomy on gastric contents.

Authors:  J M Thomas; J J Misiewicz; A R Cook; M J Hill; P L Smith; C L Walters; J K Forster; L E Martin; D F Woodings
Journal:  Gut       Date:  1987-06       Impact factor: 23.059

10.  Gastric cancer incidence and mortality is associated with altitude in the mountainous regions of Pacific Latin America.

Authors:  Javier Torres; Pelayo Correa; Catterina Ferreccio; Gustavo Hernandez-Suarez; Rolando Herrero; Maria Cavazza-Porro; Ricardo Dominguez; Douglas Morgan
Journal:  Cancer Causes Control       Date:  2012-12-07       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.